Search Results
Feb 11, 2026, 05:48 ET SK Innovation E&S akan mendukung pengembangan wirausahawan muda di bidang energi dan lingkungan di Indonesia
Pengembangan ide bisnis, pendidikan, networking, dan pendanaan untuk pemuda Indonesia - dukungan pada seluruh siklus kewirausahaanPada tanggal 11 di Jakarta, 'Majoon Networking Day' diselenggarakan, memberikan
More news about: SK Innovation E&S
Feb 09, 2026, 20:00 ET Wacom Honored with Ub Iwerks Award for Longstanding Contribution to Animation at the 53rd Annie Awards
educational initiatives and ongoing industry collaboration."We are deeply honored to receive this recognition from the Annie Awards," said Nobu Ide, President and CEO of Wacom. "This award is especially meaningful to us because it does not recognize a single product or moment in time, but rather
More news about: Wacom
Feb 09, 2026, 20:00 ET Wacom Honored with Ub Iwerks Award for Longstanding Contribution to Animation at the 53rd Annie Awards
educational initiatives and ongoing industry collaboration."We are deeply honored to receive this recognition from the Annie Awards," said Nobu Ide, President and CEO of Wacom. "This award is especially meaningful to us because it does not recognize a single product or moment in time, but rather
More news about: Wacom
Feb 09, 2026, 09:43 ET AquaFortus Enters Global Infrastructure Phase
Iris Jancik, Chief Commercial Officer (CCO): A veteran of the desalination industry and former CEO of IBAT and of IDE Americas, Jancik specializes in building the commercial coalitions and delivery models required for multi-hundred-million-dollar water assets.
More news about: AquaFortus
Feb 09, 2026, 08:00 ET TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
granted full approval of its Investigational Device Exemption (IDE) for the Next-Generation OCS ENHANCE Heart trial. This follows full FDA approval of the company's Next-Generation OCS DENOVO Lung IDE trial in January 2026 and conditional IDE approval for the ENHANCE Heart trial in August 2025.
More news about: TransMedics Group, Inc.
Feb 09, 2026, 01:43 ET Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System
Administration (NMPA) of the People's Republic of China and is currently under review. The system has also received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (U.S. FDA) to conduct an Early Feasibility Study (EFS) in the United States.Peijia Medical
More news about: Peijia Medical
Feb 09, 2026, 01:00 ET Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System
Administration (NMPA) of the People's Republic of China and is currently under review. The system has also received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (U.S. FDA) to conduct an Early Feasibility Study (EFS) in the United States.Peijia Medical
More news about: Peijia Medical
Feb 06, 2026, 12:13 ET CGTN: Telefonáty Xi Jinpinga s Putinom a Trumpom v rovnaký deň zdôrazňujú úlohu Číny pre globálnu stabilitu
/PRNewswire/ – Čínsky prezident Xi Jinping v stredu rokoval samostatne s ruským prezidentom Vladimirom Putinom a americkým prezidentom Donaldom Trumpom. Ide o zriedkavé kolo diplomatických rokovaní v ten istý deň. Spravodajstvo CGTN publikovalo článok s analýzou priorít oboch rokovaní na vysokej úrovni a
More news about: CGTN
Feb 06, 2026, 08:00 ET Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
Positive 12-month results from the VOLT-AF IDE Study presented at the AF Symposium and simultaneously published in JACC: Clinical Electrophysiology, reinforce the Volt™ Pulsed Field Ablation (PFA) System's industry-leading success rate for treating AFib1New
More news about: Abbott
Feb 05, 2026, 13:42 ET P&F Secures EU MDR CE Certification for TricValve® System
70 countries, with more than 3,000 patients treated worldwide. In the United States, TricValve is an investigational device limited to use under FDA IDE #G240065 (ClinicalTrials.gov Identifier: NCT06137807).About P&F Products and FeaturesP&F Products and Features GmbH, headquartered
More news about: P+F Products and Features
Feb 05, 2026, 10:53 ET Robin Zeng: Nástup éry udržateľnej energie s technológiou nulových uhlíkových emisií
priemyselného parku bez pripojenia k sieti. Je napájaný výlučne veternou a solárnou energiou, s akumuláciou energie na výrobu batérií s kapacitou 40 GWh. Ide o dôkaz, ako pokročilé energetické technológie dokážu vytvoriť systém s nulovou čistou spotrebou energie.Okrem distribúcie budú energetické systémy
More news about: Contemporary Amperex Technology Co., Limited (CATL)
Feb 04, 2026, 11:44 ET TCL Professional predstavuje na veľtrhu ISE 2026 digitálne značenie a komerčné LED riešenia na olympijskej úrovni
Professional, podznačka zameraná na vertikálne trhy B2B, predstavuje špeciálne komerčné zobrazovacie riešenia určené pre rôzne profesionálne prostredia. Ide o riešenia s podporou technológií displejov dodávaných spoločnosťou TCL CSOT (TCL China Star Optoelectronics Technology), svetovým lídrom v oblasti
More news about: TCL
Feb 04, 2026, 11:17 ET Midea Building Technologies predstavuje integrované riešenia pre budovy „Smart in One" na veľtrhu AHR Expo 2026
zvýšenú spoľahlivosť systému.Zjednotená odpoveď na rôzne výzvy„Naša prítomnosť na veľtrhu AHR presahuje rámec výstavy produktov. Ide o prezentáciu holistickej odpovede," povedal hovorca spoločnosti Midea Building Technologies. „Filozofia ‚Smart in One' spočíva v poskytovaní prepojených
More news about: Midea Building Technologies
Feb 04, 2026, 08:01 ET Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.Additional information can be
More news about: Aethlon Medical, Inc.
Feb 04, 2026, 06:30 ET Boston Scientific announces results for fourth quarter and full year 2025
Lithotripsy (IVL) System to treat patients with complex calcified peripheral artery disease.Completed enrollment in the global FRACTURE IDE clinical trial evaluating the use of the SEISMIQ IVL System to treat patients with complex calcified coronary artery disease.Received
More news about: Boston Scientific Corporation
Feb 03, 2026, 16:28 ET Huawei odhaľuje nové bežecké možnosti v partnerstve s tímom Eliuda Kipchogeho
očakávané, pretože majú integrovať poznatky od elitných bežcov a priniesť inovácie v oblasti presnosti údajov aj prispôsobivosti reálnemu svetu. Či už ide o uspokojenie náročných požiadaviek elitných bežcov alebo o podporu každodenných fitness nadšencov pri rozvíjaní plného tréningového potenciálu založeného
More news about: HUAWEI
Feb 03, 2026, 12:30 ET VITAMIN ANGELS CONCLUDES THREE-YEAR STRATEGY, REACHING 220 MILLION WOMEN AND CHILDREN AND ACCELERATING PROGRESS TOWARD 2033 GOAL
Through Nutrition, a consortium uniting Vitamin Angels, Helen Keller Intl, and iDE, and funded by The Church of Jesus Christ of Latter-day Saints, exceeded its reach goal by delivering essential nutrition to more than 29 million people,
More news about: Vitamin Angels
Feb 03, 2026, 11:30 ET Svetové ekonomické fórum označuje Hisense za prvý "maják zameraný na zákazníka" v globálnom odvetví televízorov
zameraného na človeka premieňame poznatky od zákazníkov na skutočnú hodnotu produktu s väčšou rýchlosťou a presnosťou."Pre spoločnosť Hisense ide už o tretie označenie „Lighthouse" v rámci siete WEF Global Lighthouse Network. Závod Hisense Hitachi v Huangdao bol predtým uznaná ako prvý maják udržateľnosti
More news about: Hisense
Feb 02, 2026, 08:00 ET Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
1-Year Data from Endospan's NEXUS TRIOMPHE IDE Trial Demonstrate High Patient Survival with Low Morbidity2-Year Data from the AMDS PERSEVERE IDE Trial Further Demonstrate the Persistent Clinical Benefit of AMDSATLANTA,
More news about: Artivion, Inc.
Feb 02, 2026, 03:08 ET Texaský inštitút srdcových arytmií v St. David's Medical Center ako prvý v USA implantuje novú defibrilačnú elektródu schválenú FDA
inštitútu pre srdcovú arytmiu (TCAI) v St. David's Medical Center nedávno ako prví v krajine implantovali novú defibrilačnú elektródu schválenú FDA. Ide o špecializovaný izolovaný drôt, ktorý sa pripája k implantovateľnému kardioverteru-defibrilátoru (ICD) alebo zariadeniu na resynchronizačnú terapiu
More news about: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center
Jan 31, 2026, 17:05 ET KANADA PODPORUJE NOVÚ BANKU PRE OBRANU, BEZPEČNOSŤ A ODOLNOSŤ
Development Group: Skupina DSRB Development Group víta vyhlásenie kanadského ministra financií, v ktorom potvrdzuje poprednú úlohu Kanady, pokiaľ ide o zriadenie Defence, Security and Resilience Bank (Banka pre obranu, bezpečnosť a odolnosť).Kanadské vedenie odráža spoločné chápanie spojencov,
More news about: Defence, Security and Resilience Bank (DSRB) Development Group
Jan 29, 2026, 11:34 ET Le Maharashtra signe à Davos des protocoles d'accord d'une valeur de 360 milliards de dollars américains, et mène des discussions approfondies pour des accords supplémentaires d'une valeur de 120 milliards de dollars américains
cumulativement des emplois potentiels pour 3 à 4 millions de personnes. Environ 83 % des investissements annoncés sont des investissements directs étrangers (IDE), et comprennent des engagements provenant de plus de 18 pays, notamment les États-Unis, le Royaume-Uni, la Suisse, la Suède, Singapour, les Pays-Bas,
More news about: Industries Department, Government of Maharashtra
Jan 29, 2026, 09:04 ET New Opsera Report Reveals How AI is Transforming Software Delivery and Driving Business Outcomes
and unmeasured code contributions.Tooling Impact: GitHub Copilot dominates with a 60–65% market share, but emerging agentic tools and IDE-centric assistants are shaping how teams work.Industry Context Matters: Organizations with automated CI/CD pipelines realize greater
More news about: Opsera
Jan 29, 2026, 09:00 ET NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization
tendinopathy, elbow, wrist, plantar fasciitis, and other musculoskeletal conditions.Nexsphere-F™ previously received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) and subsequently initiated a pivotal clinical trial for FDA approval, which is moving forward
More news about: NEXTBIOMEDICAL CO., LTD.
Jan 29, 2026, 09:00 ET Astronomer Announces the 2026 Astronomer Data Excellence Award Winners
Get started today for free with Astro IDE to ship data pipelines 10x fasterAbout AstronomerAstronomer empowers data teams to bring mission-critical software, analytics,
More news about: Astronomer